By aligning innovative scientific insights with strategic commercial pathways, the industry has the potential to fulfill its early promise – delivering safe, effective therapies that improve patient outcomes and create new opportunities for growth in the biopharmaceutical sector.
The post Beyond the Hype: The Scientific and Commercial Future of Microbiome Medicine appeared first on MedCity News.
